Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery

Arch Surg. 2011 Apr;146(4):444-7. doi: 10.1001/archsurg.2011.55.

Abstract

Background: The small intestinal bacterial overgrowth (SIBO) breath test has had positive results in 84% of patients with irritable bowel syndrome vs 20% of controls. We hypothesized that SIBO would be more prevalent in patients with symptoms consistent with irritable bowel syndrome who have undergone previous abdominal surgery.

Objective: To identify causative factors for SIBO.

Design: Retrospective review.

Setting: Tertiary colorectal surgery clinic.

Main outcome measure: Result of SIBO breath test.

Results: We identified 77 patients whose differential diagnosis included SIBO from January 1, 2005, to December 31, 2007; 18 were excluded because of noncompliance with testing and 2 because of a decision to treat SIBO without formal testing. Symptoms were chronic abdominal pain in 30 patients (53%), bloating in 25 (44%), constipation in 37 (65%), and diarrhea in 7 (12%). Mean (SD) symptom duration was 45 (22) months. Of the 57 patients enrolled in this study, 45 (79%) tested positive for SIBO and 37 (82%) of those had a history of surgery, whereas 12 (21%) tested negative for SIBO and 9 (75%) of those had a history of surgery. Of the 36 SIBO-positive patients with a history of abdominal surgery (mean number of procedures, 2), the surgery locations were as follows: female reproductive organs, 23 (64%); hindgut, 15 (42%); foregut, 8 (22%); and midgut, 6 (17%). Open surgery alone was performed in 32 patients (56%) vs laparoscopic surgery in 7 (12%). Both open and laparoscopic procedures had been performed in 6 patients (11%). Four patients (7%) had a history of small intestinal obstruction. The mean age of SIBO-positive patients was higher than that of SIBO-negative patients (57 vs 44 years; P < .01). Analysis did not reveal any clinically significant independent factor associated with SIBO.

Conclusion: Physicians should consider SIBO in the differential diagnosis of patients with normal anatomic findings and chronic lower gastrointestinal complaints.

MeSH terms

  • Adult
  • Aged
  • Anti-Infective Agents / therapeutic use
  • Bacteria / metabolism*
  • Breath Tests* / methods
  • Diagnosis, Differential
  • Digestive System Surgical Procedures / adverse effects*
  • Female
  • Gastrointestinal Agents / therapeutic use
  • Gastrointestinal Tract / pathology
  • Gram-Negative Bacteria
  • Helicobacter pylori
  • Humans
  • Hydrogen / metabolism*
  • Hydrogen-Ion Concentration
  • Intestine, Small / microbiology*
  • Irritable Bowel Syndrome / diagnosis*
  • Irritable Bowel Syndrome / drug therapy
  • Irritable Bowel Syndrome / etiology*
  • Irritable Bowel Syndrome / microbiology
  • Logistic Models
  • Male
  • Methane / metabolism*
  • Middle Aged
  • Research Design
  • Retrospective Studies
  • Rifamycins
  • Rifaximin
  • Sample Size

Substances

  • Anti-Infective Agents
  • Gastrointestinal Agents
  • Rifamycins
  • Hydrogen
  • Rifaximin
  • Methane